FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes polycyclic macrolactams of formulas (I) , (II) and (III) where means a simple bond or if R2a is absent - a double bond; optionally protected hydroxyl group and R1a-H; or R1 and R1a together mean oxo-group; R2 means optionally protected hydroxyl group or together with R4 forms -OC(=O)O-; R2a is H or absent; when symbol means a simple bond then R2 together with R2a mean optionally protected hydroxyl group or together with R2 forms -OC(=O)O-; R4a is H, or R4 together with R4a mean oxo-group; R5 means, halogen, alkoxycarbonylhydroxy-group, optionally protected hydroxyl, lower alkoxyl, acyloxyl or a group OC(x)N(R10)R11; or R5 together with R6a form a group ; or R5 together with R8a means hydroxy- -group and then R8 means hydroxyl; R6 means hydroxyl, and R6a or together with R5 forms a group -OC(=X)-N-; or R6 and R6a together form oxo-group; means optionally protected hydroxyl, lower alkoxyl or acyloxyl, and means hydroxyl; or and together form -OC(= O)O-; means hydroxyl or lower alkoxyl, and means hydroxyl; or and together form a group -OC(=O)O; R7 means methoxyl or hydroxyl; R8 means optionally protected hydroxyl-group, acyloxyl, imidazolyl- -carbonyl or alkoxycarbonyloxyl and R8a means hydrogen; or R8 means hydroxyl and R8a together with R5 mean hydroxy-group; or R8 together with R8a mean oxo-group; n = 1 or 2 in free state or as salt. Synthesized compounds show pharmacological activity and can be used in pharmaceutical composition showing antiinflammatory, immunosuppressant and antiproliferative activities. EFFECT: improved method of synthesis, enhanced effectiveness. 6 cl, 73 ex, 14 tbl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF TETRAHYDROPYRANE AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2130460C1 |
PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | 2004 |
|
RU2326118C2 |
CYCLOALKYL COMPOUNDS - INHIBITORS OF POTASSIUM CHANNELS FUNCTION | 2003 |
|
RU2343143C2 |
HYDROCARBON GEL-BASED PRODRUGS | 2013 |
|
RU2647729C2 |
DIAGNOSIS, PREVENTION AND TREATMENT OF JOINT DISEASES | 2013 |
|
RU2682676C2 |
VEGF NEUTRALISING PRODRUGS FOR THE TREATMENT OF OCULAR CONDITIONS | 2013 |
|
RU2673881C2 |
METHOD OF TREATING OR CONTROL OF HYPOPARATHYROIDUS USING PARATHROOID HORMONE (PTH) CONJUGATE | 2019 |
|
RU2806753C2 |
BENZOTHIEPINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC STATE | 1997 |
|
RU2202549C2 |
DERIVATIVES OF RAPAMYCIN AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2158267C2 |
RTN PRODRUGS | 2017 |
|
RU2747316C2 |
Authors
Dates
1999-02-10—Published
1993-05-06—Filed